A sterile barrier packaging made of plastic ensures that medical products such as cannulas or surgical instruments remain germ-free for a long time. This is the only way they can be used safely.
BIOVOX expert Maria Heckel summarised what sterility is, why we need it and whether bioplastics are suitable as a sterile barrier.
Hospital infections are a global problem: on average 8.7% of hospitalized patients and as many as 25-30% of intensive care patients suffer from infectious complications during or after hospitalization. In order to keep this number as low as possible, sterility is essential for critical medical devices. But what does “sterile” actually mean?
Sterility is a condition in which a material or object is free of living microorganisms, viruses, bacteria, fungi and yeasts, including their resting stages (e.g. spores).
Legislation has introduced safety precautions through harmonised standards and directives. What sterilization procedures and standards are available, whether sterile barrier systems made of bioplastics meet the requirements and how sustainable the whole process is – ready to take a deepdive?
What is considered sterile in theory does not succeed with 100% certainty in practice, because sterility can always be stated with only one probability. In order to be able to describe a product as “sterile”, a probability of finding a germ on a product of 1 x 10-6 has been determined
This means that no more than one viable microorganism can be detected in one million products.
Further legal requirements are quality management according to ISO 13 485 or risk management according to ISO 14 971.
In the case of smaller medical devices, sterilization takes place in packaging: the product is in a so-called sterile barrier system - usually a hard blister or soft blister made of plastic, Tyvek and/or medical paper - and is sterilized together with it (according to DIN EN 556-1).
For larger medical devices, two other options exist:
Take a look at the infographic to find out what information belongs on the packaging of a sterile product.
Healthcare facilities have re-sterilization performed on-site or by a certified service provider for reusable medical devices. This process is called "reprocessing".
Processing is costly and labour-intensive: the product must be disassembled, cleaned, disinfected and dried after use (the “contamination”). This is followed by the re-contamination-proof packaging and finally the actual sterilization, as well as, if necessary, testing and restoration of technical and functional safety.
When developing a critical medical device, the selection of the appropriate sterilization process and the selection of materials must go hand in hand. The sterilisation process shall not cause any change in the physical, mechanical or biocompatibility properties resulting in unwanted body reactions or impairment of the functionality of the product. This applies both to medical devices made of bioplastics and to sterile barrier packaging made of bioplastics.
Bioplastics can be formulated to be resistant to thermal treatment, to gamma radiation or X-ray radiation (X-ray), and to chemicals such as ethylene oxide (EO) during sterilization.
Medical Grade Plastics for medical devices are subject to strict requirements, including with regard to hygiene.
Bioplastics for medical devices or sterile barrier packaging can be formulated in such a way that they are safe even after EO, gamma or X-ray sterilization.
BIOVOX bioplastics offer in addition to reducing CO2 emissions for packaging systems and plastic components, also the highest level of safety in sterile applications.
More BIOVOX knowledge
Solvent bonding allows thermoplastics to be bonded permanently without any heat source and without any adhesive remaining. In this short and more technical article, we look at how it works, suitable solvents and the advantages of this technique.
Medical devices account for almost a quarter of a hospital’s greenhouse gas emissions. How can we make them more sustainable?
Repackaged: What does the packaging of the future look like in the pharmaceutical industry?
Plastics are an indispensable part of the modern world. At the same time, we face the challenge of minimizing their ecological footprint and finding innovative solutions for the future. In this article, we look at the environmental impact, critical ingredients and the possibility of a climate-neutral circular economy based on renewable resources.
In this article, we look at how to generate value streams from hospital waste and recycle it into the production of new medical devices and pharmaceutical packaging. In short: how the circular economy succeeds in healthcare.
Your products are made from bioplastics now – great, but how do you communicate this switch to your target group? In this article, we explain how to communicate sustainability authentically.
BIOVOX 2025
